Navigation Links
PRA International Hosts an Infectious Diseases Audio Conference
Date:12/9/2009

RALEIGH, N.C., Dec. 9 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces its Scientific Head of Infectious Diseases Carl Kraus, M.D., Vice President of Scientific Affairs will host an audio conference along with John Powers, M.D., Assistant Professor of Medicine at George Washington University, on the design and regulatory environment considerations in anti-infective drug development.

Understanding the current regulatory environment and how it will affect the study design in anti-infective drug development is critical to addressing the present concerns of disease due to drug-resistant pathogens, biothreat agents, and novel influenza strains. The need to develop drugs with acceptable risk-benefit profiles for emerging and re-emerging diseases is evident. During the presentation, Drs. Kraus and Powers will review some of the basic principles surrounding anti-infective drug development in the framework of regulatory submissions as well as provide an update on some of the most important changes in recent years related to specific anti-infective indications. A question and answer discussion on selected infectious disease indications will follow their talk.

Both Drs. Powers and Kraus were formerly with the US Food and Drug Administration. At the FDA, Dr. Powers was the lead medical officer for Antimicrobial Drug Development and Resistance Initiatives, and Dr. Kraus was a medical officer in the Division of Special Pathogens and Immunologic Drug Products. Over the years, Dr. Powers has been involved in more than 50 clinical trials as a clinical investigator, has won several teaching awards, and has published extensively in the infectious disease field. Dr. Kraus has participated in more than 20 developmental programs for antiviral, antibiotic and biothreat agents and currently heads the Infectious Diseases Research Center (IDRC) at PRA.

PRA's IDRC is a cross-function
'/>"/>

SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
2. Reportlinker Adds Chiral Technology - International Technology & Market Trends
3. Swissray International Announces New Ownership
4. Chindex International to Present at Piper Jaffray Health Care Conference
5. SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts
6. International Operation Combats Online Supply of Counterfeit and Illegal Medicines
7. Lexington International, LLC Receives 2009 U.S. Presidents E Award Recognizing its Export Achievements
8. Varian Medical Systems to Showcase the Latest X-Ray Image Detectors and X-Ray Tubes at the MEDICA 2009 International Trade Fair
9. 2009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name
10. DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose.
11. Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
(Date:11/26/2014)... SHANGHAI , Nov. 26, 2014  CARsgen, a ... (CAR-T) cell immunotherapy to treat a variety of cancers, ... led by BVCF, a China -based ... an immunotherapy company focused on the development of new ... collaboration with Shanghai Cancer Institute and Shanghai Renji Hospital, ...
(Date:11/26/2014)... N.C. , Nov. 25, 2014  At the ... Antonio this October, KaVo Kerr Group was ... Technology Expo, offering attendees the opportunity to see and ... well-respected key opinion leaders deliver lectures on the latest ... Group products include the new DEXIS CariVu Caries Detection ...
Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5CARsgen Completes Series A Financing 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3
... , Jan. 29 EP Global Communications, Inc. ... ), the parent company of Exceptional Parent ( EP ) ... has joined the EPGL Advisory Board. Dr. DeFelice is one of the ... term "nutraceutical."  , "This addition to our team of experts will ...
... , PITTSBURGH , Jan. 29 ... subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. ... Application (ANDA) for Polyethylene Glycol 3350 and Electrolytes for Oral ... , Polyethylene Glycol 3350 and Electrolytes for Oral Solution ...
Cached Medicine Technology:EP Global Communications, Inc. Welcomes Stephen DeFelice, MD, to Advisory Board 2EP Global Communications, Inc. Welcomes Stephen DeFelice, MD, to Advisory Board 3Mylan Receives Approval for Generic Version of GoLytely(R) 2
(Date:11/28/2014)... Celebration can quickly turn to tragedy if popular turkey ... Over the last decade, more than 141 serious fires ... turkey fryers, according to the U.S. Consumer Product Safety ... who tried to deep fry the turkey indoors, which ... Arthur Sanford, a burn surgeon at Loyola University Health ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Not only ... create products free of petroleum, parabens and other cancer-causing ... that fund research, education and awareness programs that help ... staff and owners have raised an incredible, record-breaking contribution ... the Cure, sales of the Sweet Red Rose Whip ...
(Date:11/28/2014)... Angeles, CA (PRWEB) November 28, 2014 ... online, reported during the hugely popular, 2014 ... the antismoking organization Truth launched ground-breaking celebrity centered ... 18-49. The MTV viewership figures were estimated by ... Truth antismoking ads placed the spotlight on celebrities ...
(Date:11/28/2014)... 28, 2014 A newly released article ... overview of the influenza virus that will soon be spreading ... , The article begins with a brief explanation of what ... It reminds families that children under the age of 5, ... chronic diseases, such as heart and lung diseases, asthma, or ...
(Date:11/28/2014)... November 28, 2014 Patten Pecans, based ... grown. With those passions driving them, they've added a ... Having tried other pecans oils, they've found this ... to be exceptionally flavorful, retaining the buttery pecan notes ... nutritional benefits found in pecans nuts is ...
Breaking Medicine News(10 mins):Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 2Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 3Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 4Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 5Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2Health News:Patten Pecans Goes Local with Nutritious Georgia Pecan Oil 2
... procedures, survey shows , FRIDAY, July 31 (HealthDay News) -- ... visited a plastic surgeon for a "makeover" -- a ... around her lips and at the corners of her mouth. ... might lose her competitive edge in a tightening job market. ...
... , , WASHINGTON, July 31 ... Tobacco-Free Kids: , , (Logo: ... Council has taken an important step to protect the District,s kids and ... tax by 50 cents to $2.50 per pack - the seventh highest ...
... Fla., July 31 Sanofi-aventis US announced yesterday that the FDA ... in the USA. It offers results that last for years. Dr ... the product while abroad. It was approved in Europe(CE) for over ... global pharmaceutical company. The FDA approval is based on results from ...
... Md., July 31 /PRNewswire-Asia/ -- Chindex International, Inc.,("Chindex") (Nasdaq: ... products and services in the People,s Republic of China, today,announced ... results,on Monday, August 10, 2009, before the market opens. Management ... 10, 2009 to discuss financial results. , ...
... , , ... Administration (FDA) today approved the first and only antipsychotic for ... were approved for the acute treatment of schizoaffective disorder either ... INVEGA(R) was approved in 2006 for the treatment of schizophrenia. ...
... , Campaign Officially Launches ... months of college students and others wrestling with the creative challenge ... for its nationwide sign design contest. The victors are Kelsey Hazzard, ... law school this fall at the University of Virginia, and Christina ...
Cached Medicine News:Health News:Plastic Surgeons Stay Busy in Recession 2Health News:Plastic Surgeons Stay Busy in Recession 3Health News:District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 2Health News:Chindex International, Inc. to Report First Quarter Fiscal 2010 Financial Results 2Health News:INVEGA(R) Approved as the First and Only Treatment for Schizoaffective Disorder 2Health News:INVEGA(R) Approved as the First and Only Treatment for Schizoaffective Disorder 3Health News:INVEGA(R) Approved as the First and Only Treatment for Schizoaffective Disorder 4Health News:INVEGA(R) Approved as the First and Only Treatment for Schizoaffective Disorder 5Health News:INVEGA(R) Approved as the First and Only Treatment for Schizoaffective Disorder 6Health News:INVEGA(R) Approved as the First and Only Treatment for Schizoaffective Disorder 7Health News:CandleInTheWindow.org Announces $1000 Scholarship Prize Winners 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: